DocGo (DCGO) Aktsia Kursus

DocGo Kursus

NASDAQ·SULETUD
0,27
​
Turg suletud

Viimase 6 aasta jooksul kasvas DocGo käive 37,2 % aastas ja jõudis 322,20 M USD-ni. Kasum aktsia kohta langes 6,1 % aastas viimase 3 aasta jooksul. DocGo netomarginaal −56,6 % on langenud võrreldes 7,4 %-ga mõni aasta tagasi.

DocGo aktsiahinnad

Hangi need andmed Eulerpool API kaudu

100 000 päringut/kuus tasuta · krediitkaarti pole

DocGo ärimudel ja aktsia analüüs

DocGo Inc'i ajalugu algas 2014. aastal, kui tekkis idee luua mobiilirakendus arstide vastuvõtule registreerumiseks ja tervise jälgimiseks. Asutajad märkasid kiirema ja mugavama ligipääsu vajadust meditsiinilistele teenustele. Sellest visioonist sai alguse DocGo Inc. DocGo Inc-i ärimudel hõlmab mitmesuguseid mobiilirakendusi, mis parandavad juurdepääsu tervishoiuteenustele. Põhirakendus on DocGo, mis võimaldab kasutajatel broneerida arstivisiite ning jälgida ja hallata oma tervisedata. See rakendus pakub ka funktsiooni krooniliste haiguste, nagu diabeet või kõrge vererõhk, jälgimiseks ning saadab automaatselt arstile aruandeid nende seisunditest. Teine oluline DocGo toode on telemeditsiinisüsteem, mis võimaldab kasutajatel saada varaseid hinnanguid ja diagnoose arstidelt video- ja vestluskanali kaudu. See aitab vältida paljusid juhtumeid, kus patsiendid peavad füüsiliselt arsti juurde minema, säästes aega ja raha. DocGo on arendanud ka mobiilapteegi rakenduse, mis võimaldab patsientidel tellida oma ravimeid otse rakenduse kaudu ja saada need koju tarnituna. See rakendus sisaldab interaktiivseid funktsioone, nagu meeldetuletusfunktsioon, mis teavitab kasutajat, millal tuleb ravimeid võtta. Teine oluline aspekt DocGo-s on selle integratsioon kannetavate seadmetega, mis võimaldab kasutajatel mõõta ja saata oma tervisedata reaalajas rakendusse. DocGo kasutab ka tehisintellekti ja masinõppimist, et tuvastada kasutajate tervislikke riske ning anda soovitusi ravimite ja ravi kohta. Viimasel ajal on DocGo laienenud erinevates valdkondades. Ettevõte on sõlminud partnerlussuhteid suurte tervishoiuorganisatsioonide ja haigladega, et luua laiem hooldusvõrgustik. DocGo on arendanud ka API-d, mis võimaldab teistel ettevõtetel integreerida oma tervisedata DocGo süsteemi. Üldiselt on DocGo teinud olulise panuse tervishoiuteenuste ligipääsu parandamisse, eriti COVID-19 pandeemia ajal. Pakkudes telemeditsiini- ja mobiilapteegi teenuseid ning haldades tervisedata, on DocGo aidanud demokraatlikustada ja täiustada tervishoidu.

Korduma kippuvad küsimused DocGo aktsia kohta

The business model of DocGo Inc revolves around providing on-demand medical transportation services. As a mobile medical transportation platform, DocGo Inc utilizes advanced technology to connect healthcare providers, patients, and medical transportation providers. Through their efficient platform, DocGo Inc ensures timely and reliable transportation for patients with non-emergency medical needs, enhancing access to medical care. By offering this convenient and reliable solution, DocGo Inc aims to improve the overall healthcare experience and help healthcare providers streamline their operations.

DocGo Inc is primarily active in the healthcare industry.

The main competitors of DocGo Inc in the market include companies like E-Trip, MedTech Solutions, and HealthNet Innovations.

DocGo Inc is a leading company in the healthcare industry. Founded in [year], it has established itself as a trusted provider of innovative healthcare solutions. With a strong focus on improving patient outcomes, DocGo Inc offers a wide range of services including telehealth, remote patient monitoring, and medical device development. The company has a team of highly skilled professionals dedicated to delivering state-of-the-art technology and personalized care. DocGo Inc has consistently demonstrated its commitment to revolutionizing the healthcare industry, and its name has become synonymous with excellence and cutting-edge advancements in the field.

Some significant milestones achieved by DocGo Inc include the successful development and launch of their advanced medical technology solutions, which have revolutionized the healthcare industry. The company has also garnered recognition for their groundbreaking research and innovation in areas such as telemedicine, patient monitoring, and data analysis. DocGo Inc's commitment to excellence is demonstrated through their partnerships with leading healthcare organizations and the continuous improvement of their products and services. With a focus on improving patient outcomes and delivering high-quality healthcare solutions, DocGo Inc continues to make significant strides in the industry.

DocGo Inc is primarily present in multiple countries and regions around the world. Some of the key locations where DocGo Inc operates include the United States, Canada, Europe, and Asia. With a global presence, DocGo Inc has established a strong foothold in these regions, allowing them to provide their stock services and solutions to a wide range of international clients. Whether you are based in North America, Europe, or Asia, DocGo Inc is committed to delivering exceptional stock services and maintaining a strong presence in multiple countries and regions.

DocGo Inc represents a strong commitment to providing quality healthcare services through innovative technologies and a patient-centric approach. The company values include integrity, transparency, and a passion for improving healthcare outcomes. DocGo Inc strives to revolutionize the medical transportation industry by offering efficient and reliable services that prioritize patient safety and comfort. With a customer-focused philosophy, DocGo Inc aims to deliver exceptional value to both its clients and shareholders.

11 analüütikut hindavad praegu DocGo aktsiat: 7 soovitab osta, 4 hoida ja 0 müüa. 2026. aastaks ootavad analüütikud, et DocGo teenib tulu 306,50 M USD ja kasumit aktsia kohta −0,51 USD.

Praeguse kursiga kaubeldakse DocGo aktsiaga 0,24 EUR (0,27 USD) juures.

DocGo aktsia (DCGO) on noteeritud 1 börsil, sh: NASDAQ (DCGO).

DocGo Inc is an innovative company specialized in providing medical services through mobile health and care teams. Its business model includes various divisions and products that enable the company to effectively and efficiently meet the needs of customers and patients. One of the main divisions of DocGo Inc is the provision of medical services for patients in emergencies. This includes providing mobile intensive care units that can offer immediate medical assistance to patients in critical conditions. The teams of DocGo Inc are specially trained and equipped to act quickly and safely in any situation. This service is particularly important for patient transportation between facilities or to bridge waiting times for appointments. Another important division of DocGo Inc is telemedicine. This involves the medical care of patients through digital communication means such as phone calls, video calls, and text messages. This type of medical care is especially suitable for patients who have difficulties accessing a clinic or hospital. Additionally, it can help reduce long waiting times at the doctor's office or in the emergency room. DocGo Inc's telemedicine is easily accessible and provides a fast and reliable connection to an experienced doctor. Another product offered by DocGo Inc is mobile diagnostics. This includes conducting medical tests and examinations through mobile teams that come directly to the patient's location. This product is particularly suitable for people who have difficulties accessing a clinic or hospital but still require medical examinations. The mobile teams of DocGo Inc are specially trained and equipped with the latest medical devices and technologies. Furthermore, DocGo Inc also offers training for medical personnel and laypeople, especially those working or living in emergency situations. These trainings include courses in first aid, life-saving techniques, and medical care. These trainings are invaluable for companies and organizations that want to prepare their employees for emergencies, as well as for individuals who want to be ready to act in emergency situations. Overall, the business model of DocGo Inc is focused on providing medical services to patients quickly, reliably, and with minimal restrictions. The mobile teams of DocGo Inc are highly qualified and specially trained to act quickly and safely in any situation. The telemedicine and mobile diagnostics services are particularly suitable for patients who have difficulties accessing clinics or hospitals. Finally, DocGo Inc's trainings improve the skills of medical personnel and laypeople, ultimately saving lives in emergencies.

oodatav DocGo käive on 306,50 M USD. See näitaja põhineb praegusel finantsandmetel ja peegeldab ettevõtte äritulemuseid.

oodatav DocGo kasum on −49,64 M USD. Netokasum peegeldab ettevõtte kasumlikkust pärast kõigi kulude mahaarvamist.

Võrdlusarvud hinna ja kasumiga (P/E) DocGo jaoks on praegu −0,54. P/E-suhtarv võrdleb praegust aktsiahinnad kasumiga aktsia kohta ja aitab investoritel hinnata DocGo aktsia väärtust.

Kursuse ja müügimahu suhe (P/S) DocGo jaoks on praegu 0,09. P/S-suhtarv võrdleb börsikapitalisatsooni aastase tuluga ja teenib hindamismõõdikuna DocGo aktsia jaoks.

Eulpooli kvaliteedinäitaja DocGo jaoks on 1/10.

DocGo ISIN on US2560861096. ISIN (rahvusvaheline väärtpaberi identifitseerimise number) on väärtpaberite globaalne unikaalne tuvastaja.

DocGo ticker on DCGO. Ticker-sümbol kasutatakse DocGo aktsiate kauplemiseks börsil.

Õiglane väärtusTerminal
0,23 USD
Üle-/alahinnangTerminal
Õiglaselt hinnatakse
Tööstus
Tervishoiuteenijad ja teenused
Aktsiate arv
Töötajad
Tulu töötaja kohta
188 860,49 USD
Tulukasvu keskmine 5 aastat
EBIT kasvu keskmine 5 aastat
Puhaskasumi kasvu keskmine 5 aastat
Veebisait docgo.com
Valuuta
USD
Börsi noteerimise algus
15. okt 2020
ISIN
US2560861096
CUSIP
256086109
SEDOL
BKP4P23
Turukapitalisatsioon
26,60 M USDMicro Cap
52-nädala vahemik
PEG
0,01
P/E suhe
P/E e 2026
−0,54
P/E e 2027
−1,01
P/E e 2028
−0,85
P/S
P/S e
0,09
EV/EBIT
—
P/B suhe
0,18
ROE (omakapitali tootlus)
ROA (varatootlus)
ROCE (kasutatud kapitali tootlus)
ROIC (investeeritud kapitali tootlus)
−105,32 %
Viimati värskendatud 19. okt 2026, 08:43

DocGo konkurendid

DocGo Börsiticker

NASDAQ · DCGO

DocGo FIGI

DCGO:US · BBG00YB8JBK8DCGO:UA · BBG00YHLH5S0DCGO:UC · BBG00YHLH5T9DCGO:UN · BBG00YHLH5W5DCGO:UP · BBG00YHLH5X4DCGO:UB · BBG00YHLH5Z2DCGO:UM · BBG00YHLH617DCGO:UX · BBG00YHLH626DCGO:UR · BBG00YHLH635DCGO:UD · BBG00YHLH671DCGO:UF · BBG00YHLH6B6DCGO:VY · BBG00YHLH6C5

Kõik teised näitajad ja analüüsid DocGo kohta sügavamalt

Meie DocGo-aktsia analüüs sisaldab olulisi finantsnäitajaid, nagu käive, kasum, P/E suhe, P/S suhe, EBIT, samuti teavet dividendi kohta. Lisaks käsitleme aspekte nagu aktsiad, turukapitalisatsioon, võlad, omakapital ja kohustused ettevõttes DocGo. Kui otsite nende teemade kohta põhjalikumat teavet, pakume teile meie alamlehtedel üksikasjalikke analüüse: